Cymabay Therapeu Price on May 19, 2023
| CBAYDelisted Stock | USD 11.83 0.27 2.34% |
If you're considering investing in Cymabay Stock, it is important to understand the factors that can impact its price. As of today, the current price of Cymabay Therapeu stands at 11.83, as last reported on the 9th of January, with the highest price reaching 12.43 and the lowest price hitting 11.52 during the day. We have found eight technical indicators for Cymabay Therapeu, which you can use to evaluate the volatility of the firm. Please confirm Cymabay Therapeu's Rate Of Daily Change of 1.02, day typical price of 11.93, and Accumulation Distribution of 0.0732 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
Cymabay Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Cymabay |
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| CBAY |
Based on monthly moving average Cymabay Therapeu is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cymabay Therapeu by adding Cymabay Therapeu to a well-diversified portfolio.
Cymabay Therapeu Valuation on May 19, 2023
It is possible to determine the worth of Cymabay Therapeu on a given historical date. On May 19, 2023 Cymabay was worth 9.05 at the beginning of the trading date compared to the closed value of 9.11. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cymabay Therapeu stock. Still, in general, we apply an absolute valuation method to find Cymabay Therapeu's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cymabay Therapeu where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cymabay Therapeu's related companies.
| Open | High | Low | Close | Volume | |
| 9.15 | 9.29 | 9.00 | 9.05 | 1,099,050 | |
05/19/2023 | 9.05 | 9.20 | 8.93 | 9.11 | 1,382,680 |
| 9.07 | 9.27 | 8.68 | 8.76 | 1,296,973 |
| Backtest Cymabay Therapeu | | | Cymabay Therapeu History | | | Cymabay Therapeu Valuation | Previous | Next |
Cymabay Therapeu Trading Date Momentum on May 19, 2023
| On May 22 2023 Cymabay Therapeu was traded for 8.76 at the closing time. The top price for the day was 9.27 and the lowest listed price was 8.68 . The trading volume for the day was 1.3 M. The trading history from May 22, 2023 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 3.84% . The overall trading delta against the current closing price is 3.84% . |
Cymabay Therapeu Fundamentals Correlations and Trends
By evaluating Cymabay Therapeu's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cymabay Therapeu's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cymabay financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Cymabay Therapeu Stock history
Cymabay Therapeu investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cymabay is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cymabay Therapeu will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cymabay Therapeu stock prices may prove useful in developing a viable investing in Cymabay Therapeu
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. CymaBay Therapeutics, Inc. was incorporated in 1988 and is headquartered in Newark, California. Cymabay Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 59 people.
Cymabay Therapeu Stock Technical Analysis
Cymabay Therapeu technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Cymabay Therapeu Period Price Range
Low | January 9, 2025
| High |
0.00 | 0.00 |
Cymabay Therapeu cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Cymabay Therapeu January 9, 2025 Market Strength
Market strength indicators help investors to evaluate how Cymabay Therapeu stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cymabay Therapeu shares will generate the highest return on investment. By undertsting and applying Cymabay Therapeu stock market strength indicators, traders can identify Cymabay Therapeu entry and exit signals to maximize returns
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Cymabay Stock
If you are still planning to invest in Cymabay Therapeu check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cymabay Therapeu's history and understand the potential risks before investing.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |